相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mo1849 Mechanism of Action for Linaclotide Induced Abdominal Pain Relief
Joel Castro et al.
GASTROENTEROLOGY (2015)
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints
E. M. M. Quigley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Guanylate cyclase-C receptor activation: unexpected biology
Stuart M. Brierley
CURRENT OPINION IN PHARMACOLOGY (2012)
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
M. Ke et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Clarification of trial end points presented in a recent review of linaclotide Response
Jeffrey M. Johnston et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome
P. Clave et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis
Nicole C. Suares et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Current and future therapies for chronic constipation
J. Tack
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Quality of life in children and adults with constipation
Arnold Wald et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey
Shawn X. Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Diagnosis and treatment of chronic constipation - a European perspective
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Two Randomized Trials of Linaclotide for Chronic Constipation
Anthony J. Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases
Lincoln R. Potter
PHARMACOLOGY & THERAPEUTICS (2011)
Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design
Ann Marie Trentacosti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
Charles F. Barish et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Robert W. Busby et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
Jeffrey M. Johnston et al.
GASTROENTEROLOGY (2010)
Efficacy of Linaclotide for Patients With Chronic Constipation
Anthony J. Lembo et al.
GASTROENTEROLOGY (2010)
Current Medical Treatments of Dyspepsia and Irritable Bowel Syndrome
Michael Camilleri et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract
Alexander P. Bryant et al.
LIFE SCIENCES (2010)
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain
H. Eutamene et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
Anthony Lembo et al.
GASTROENTEROLOGY (2010)
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
D. A. Drossman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study
E. M. M. Quigley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation
Jeffrey M. Johnston et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future Directions
Jan Tack et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
J. Tack et al.
GUT (2009)
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation
J. F. Johanson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation
John F. Johanson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
5-HT4 receptor agonists:: similar but not the same
J. H. De Maeyer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
A placebo-controlled trial of prucalopride for severe chronic constipation
Michael Camilleri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome
Viola Andresen et al.
GASTROENTEROLOGY (2007)
Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Drugs acting on serotonin receptors for the treatment of functional GI disorders
Marcello Tonini et al.
DIGESTIVE DISEASES (2006)
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
J Tack et al.
GUT (2005)
Tegaserod for the treatment of chronic constipation:: A randomized, double-blind, placebo-controlled multinational study
MA Kamm et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The health-related quality of life and economic burden of constipation
C Dennison et al.
PHARMACOECONOMICS (2005)
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
H Nyhlin et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Effect of Tegaserod in Chronic Constipation: A Randomized, Double-Blind, Controlled Trial
John F. Johanson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Current concepts: Chronic constipation
A Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
J Novick et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
分享论文
